Clinical Trial Update: Novel Induction to Buprenorphine/Naloxone [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating novel induction to buprenorphine/naloxone for opioid use disorder has been terminated. The study was sponsored by Bicycle Heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: Bicycle Health | Conditions: Opioid Use Disorder, Opioid Use | Phase 4 | Status: TERMINATED